Paul Tudor Jones's CVS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 168,000 shares of CVS Health Corporation (CVS) worth $13.33 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 619,958 shares. Largest reduction occurred in Q1 2025, reducing 977,703 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +168,000 | New Buy | 168,000 | $79.36 |
| Q1 2025 | -977,703 | Sold Out | 0 | $0.00 |
| Q4 2024 | +619,958 | Add 173.30% | 977,703 | $44.89 |
| Q3 2024 | +285,901 | Add 397.95% | 357,745 | $62.88 |
| Q2 2024 | +71,844 | New Buy | 71,844 | $59.06 |
| Q1 2024 | -3,305 | Sold Out | 0 | $0.00 |
| Q4 2023 | -491,354 | Reduce 99.33% | 3,305 | $78.96 |
| Q3 2023 | +114,549 | Add 30.14% | 494,659 | $69.82 |
| Q2 2023 | -79,058 | Reduce 17.22% | 380,110 | $69.13 |
| Q1 2023 | +268,042 | Add 140.24% | 459,168 | $0.07 |
| Q4 2022 | +181,427 | Add 1870.57% | 191,126 | $0.09 |
| Q3 2022 | -62,711 | Reduce 86.61% | 9,699 | $95.37 |
| Q2 2022 | -26,521 | Reduce 26.81% | 72,410 | $92.67 |
| Q1 2022 | +57,827 | Add 140.68% | 98,931 | $101.21 |
| Q4 2021 | +14,159 | Add 52.55% | 41,104 | $103.15 |
| Q3 2021 | +26,945 | New Buy | 26,945 | $84.88 |
| Q2 2021 | -24,013 | Sold Out | 0 | $0.00 |
| Q1 2021 | +20,746 | Add 635.02% | 24,013 | $75.21 |
| Q4 2020 | -97,603 | Reduce 96.76% | 3,267 | $68.26 |
| Q3 2020 | +66,762 | Add 195.74% | 100,870 | $58.40 |
| Q2 2020 | +34,108 | New Buy | 34,108 | $64.97 |
| Q1 2020 | -33,376 | Sold Out | 0 | $0.00 |
| Q4 2019 | +33,376 | New Buy | 33,376 | $74.30 |
| Q3 2019 | -80,649 | Sold Out | 0 | $0.00 |
| Q2 2019 | +58,264 | Add 260.28% | 80,649 | $54.50 |
| Q1 2019 | +22,385 | New Buy | 22,385 | $53.92 |
| Q2 2018 | -36,809 | Sold Out | 0 | $0.00 |
| Q1 2018 | +8,589 | Add 30.44% | 36,809 | $62.21 |
| Q4 2017 | +28,220 | New Buy | 28,220 | $72.50 |
| Q2 2017 | -59,741 | Sold Out | 0 | $0.00 |
| Q1 2017 | +30,796 | Add 106.39% | 59,741 | $78.51 |
| Q4 2016 | +22,114 | Add 323.73% | 28,945 | $78.91 |
| Q3 2016 | -26,336 | Reduce 79.40% | 6,831 | $89.01 |
| Q2 2016 | +33,167 | New Buy | 33,167 | $95.73 |
| Q1 2016 | -8,633 | Sold Out | 0 | $0.00 |
| Q4 2015 | +6,033 | Add 232.04% | 8,633 | $97.76 |
| Q3 2015 | -600 | Reduce 18.75% | 2,600 | $96.54 |
| Q2 2015 | -91,583 | Reduce 96.62% | 3,200 | $105.00 |
| Q1 2015 | +82,936 | Add 700.06% | 94,783 | $103.21 |
| Q4 2014 | +11,847 | New Buy | 11,847 | $96.31 |
| Q3 2014 | -5,542 | Sold Out | 0 | $0.00 |
| Q2 2014 | +5,542 | New Buy | 5,542 | $75.42 |
| Q4 2013 | -10,500 | Sold Out | 0 | $0.00 |
| Q3 2013 | +4,200 | Add 66.67% | 10,500 | $56.76 |
| Q2 2013 | +6,301 | Add 0.00% | 6,300 | $57.14 |
Paul Tudor Jones's CVS Health Corporation Investment FAQs
Paul Tudor Jones first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 6,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held CVS Health Corporation (CVS) for 45 quarters since Q2 2013.
Paul Tudor Jones's largest addition to CVS Health Corporation (CVS) was in Q4 2024, adding 977,703 shares worth $43.89 M.
According to the latest 13F filing for Q4 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 168,000 shares of CVS Health Corporation (CVS), valued at approximately $13.33 M.
As of the Q4 2025 filing, CVS Health Corporation (CVS) represents approximately 0.02% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in CVS Health Corporation (CVS) was 977,703 shares, as reported at the end of Q4 2024.